This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gioia, G. Articles by Iskandrian, A. E. Search for Related Content PubMed PubMed Citation Articles by Gioia, G. Articles by Iskandrian, A. E.

(Circulation. 1997;95:390-394.)
© 1997 American Heart Association, Inc.

Articles

Prediction of Outcome of Patients With Life-Threatening Ventricular Arrhythmias Treated With Automatic Implantable Cardioverter-Defibrillators Using SPECT Perfusion Imaging

Giuseppe Gioia, MD; Bruce Bagheri, MD; Charles D. Gottlieb, MD; David S. Schwartzman, MD; David J. Callans, MD; Frank E. Marchlinski, MD; Jaekyeong Heo, MD; Ami E. Iskandrian, MD

the Division of Cardiology, Department of Medicine, MCP Hahnemann School of Medicine, Allegheny University of the Health Sciences, Philadelphia, Pa.

Background In the present study, we examined the predictors of outcome of 103 patients with coronary artery disease and left ventricular dysfunction who had life-threatening ventricular arrhythmias and were treated with implantable cardioverter-defibrillators with the use of single-photon emission computed tomography (SPECT).

Methods and Results During a mean follow-up of 29 months, there were 29 cardiac deaths. In comparison with patients who died, survivors had less diabetes mellitus (45% versus 19%, P<.007), higher left ventricular ejection fraction (23±9% versus 27±11%, P=.04), and fewer perfusion defects as determined with stress SPECT (15±5 versus 12±5, P<.004). Most of the perfusion defects were fixed, indicative of scarring; the extent of reversible defects did not differ (2±3 in survivors and 3±4 in nonsurvivors). Multivariate Cox survival analysis identified the number of fixed defects as the only independent predictor of death (²=10, P=.002). There were six deaths among 42 patients (14%) with <8 fixed defects compared with 23 deaths among 61 patients (38%) with 8 defects (P=.005). The 4-year survival was better in patients with <8 segmental fixed defects than in those with 8 fixed defects (80% versus 36%) (²=8, P=.005).

Conclusions The myocardial perfusion pattern is an important determinant of outcome in patients with life-threatening ventricular arrhythmias who are treated with a implantable cardioverter-defibrillator. The extent of scarring separates patients into high- and low-risk groups with a 2.7-fold difference in death rate.

Key Words: arrhythmias • imaging • prognosis • tomography • tachycardia

This article has been cited by other articles:

				J. P. Piccini, J. R. Horton, L. K. Shaw, S. M. Al-Khatib, K. L. Lee, A. E. Iskandrian, and S. Borges-Neto Single-Photon Emission Computed Tomography Myocardial Perfusion Defects Are Associated With an Increased Risk of All-Cause Death, Cardiovascular Death, and Sudden Cardiac Death Circ Cardiovasc Imaging, November 1, 2008; 1(3): 180 - 188. [Abstract] [Full Text] [PDF]

				A. Elhendy, S. Chapman, T. R. Porter, and J. Windle Association of Myocardial Ischemia With Mortality and Implantable Cardioverter-Defibrillator Therapy in Patients With Coronary Artery Disease at Risk of Arrhythmic Death J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1721 - 1726. [Abstract] [Full Text] [PDF]

				K. P. Anderson Lipid-lowering therapy for prevention of ventricular tachyarrhythmias J. Am. Coll. Cardiol., July 2, 2003; 42(1): 88 - 92. [Full Text] [PDF]

				L. J. Shaw, A. E. Iskandrian, R. Hachamovitch, G. Germano, H. C. Lewin, T. M. Bateman, and D. S. Berman Evidence-Based Risk Assessment in Noninvasive Imaging J. Nucl. Med., September 1, 2001; 42(9): 1424 - 1436. [Abstract] [Full Text] [PDF]

				J De Sutter, R Tavernier, C Van de Wiele, J De Backer, J Kazmierczak, G De Backer, R Dierckx, and L Jordaens QT dispersion is not related to infarct size or inducibility in patients with coronary artery disease and life threatening ventricular arrhythmias Heart, May 1, 1999; 81(5): 533 - 538. [Abstract] [Full Text]